Skip to main content
. 2001 Mar 13;98(6):3180–3184. doi: 10.1073/pnas.051003498

Figure 3.

Figure 3

Distribution of ubiquitinated proteins and Cbl upon activation with multivalent antigen with or without MeCD treatment. Activated RBL cells were immunolabeled with polyclonal anti-Cbl antibodies plus TRITC-conjugated anti-rabbit antibodies. Costaining was performed by using either FITC-conjugated anti-DNP antibodies or monoclonal anti-HA primary plus FITC-conjugated secondary antibodies. Merged pictures are shown. (Bars = 10 μm.)